Page last updated: 2024-10-18

dihydroxyphenylalanine and Neoplasm Metastasis

dihydroxyphenylalanine has been researched along with Neoplasm Metastasis in 51 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.

Research Excerpts

ExcerptRelevanceReference
"This work was performed to evaluate the performance of (18)F-fluorodihydroxyphenylalanine ((18)F-FDOPA) PET/CT in detecting primary neuroendocrine tumors (NETs) occult on morphologic and functional imaging, in relation to tumor origin and differentiation."7.8018F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. ( Bachellier, P; Detour, J; Duclos, B; Gabriel, S; Goichot, B; Imperiale, A; Kurtz, JE; Namer, IJ; Rust, E; Taïeb, D, 2014)
"In case of uncharacteristic patient complaints or slightly pathologic BSR or liver enzyme levels in patients, suffering from melanoma, the determination of 5-S-cysteinyldopa in the 24-h-urine may be of great diagnostic value."7.66[5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients]. ( Graef, V; Hellwich, M; Paul, E; Ruppel, R, 1983)
"This study examines 5-S-cysteinyldopa, which is a melanoma-associated marker, and sialic acid whose increase appears to be a common feature of numerous cancers."7.66Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas. ( Berthelot, P; Decaux, F; Jardillier, JC; Kalis, B; Marnot, D; Warren, L, 1983)
"In a total of 1,828 determinations, urinary excretion of 5-S-Cysteinyldopa was studied over a period of three years in 384 patients treated for melanoma or with metastases of malignant melanoma."7.66[5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations]. ( Graef, V; Paul, E; Ruppel, R, 1980)
"Determinations of the urinary excretion of 5-S-cysteinyldopa were performed in 571 patients previously treated by surgery for melanoma or melanoma metastasis."7.665 years' experience of 5-S-cysteinyldopa in melanoma diagnosis. ( Agrup, G; Agrup, P; Andersson, T; Hafström, L; Hansson, C; Jacobsson, S; Jönsson, PE; Rorsman, H; Rosengren, AM; Rosengren, E, 1979)
"Determination of urine cysteinyldopa excretion is the most sensitive chemical test for the detection of melanoma metastases and has been successfully applied during the Scandinavian winter, when sun irradiation is low."7.66The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience. ( Nixon, PF, 1978)
"With the aid of gas chromatography and mass spectrometry a metabolite of dopa, 3-methoxytyrosine, has been demonstrated in the urine of 2 patients with melanoma metastases, the amounts excreted being 4."7.65Demonstration of 3-methoxytyrosine in the urine of melanoma patients. ( Agrup, G; Bengtsson, M; Falck, B; Persson, K; Rorsman, H; Rosengren, AM; Rosengren, E, 1976)
"A newly discovered amino acid, 5-S-cysteinyldopa, present in the urine of healthy subjects is excreted in pathological amounts in many patients suffering from melanoma metastases."7.655-S-cysteinyldopa in the urine of melanoma patients. ( Agrup, G; Agrup, P; Andersson, T; Falck, B; Hansson, JA; Jacobsson, S; Rorsman, H; Rosengren, AM; Rosengren, E, 1977)
"This work was performed to evaluate the performance of (18)F-fluorodihydroxyphenylalanine ((18)F-FDOPA) PET/CT in detecting primary neuroendocrine tumors (NETs) occult on morphologic and functional imaging, in relation to tumor origin and differentiation."3.8018F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. ( Bachellier, P; Detour, J; Duclos, B; Gabriel, S; Goichot, B; Imperiale, A; Kurtz, JE; Namer, IJ; Rust, E; Taïeb, D, 2014)
"In case of uncharacteristic patient complaints or slightly pathologic BSR or liver enzyme levels in patients, suffering from melanoma, the determination of 5-S-cysteinyldopa in the 24-h-urine may be of great diagnostic value."3.66[5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients]. ( Graef, V; Hellwich, M; Paul, E; Ruppel, R, 1983)
"This study examines 5-S-cysteinyldopa, which is a melanoma-associated marker, and sialic acid whose increase appears to be a common feature of numerous cancers."3.66Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas. ( Berthelot, P; Decaux, F; Jardillier, JC; Kalis, B; Marnot, D; Warren, L, 1983)
"In a total of 1,828 determinations, urinary excretion of 5-S-Cysteinyldopa was studied over a period of three years in 384 patients treated for melanoma or with metastases of malignant melanoma."3.66[5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations]. ( Graef, V; Paul, E; Ruppel, R, 1980)
"Determinations of the urinary excretion of 5-S-cysteinyldopa were performed in 571 patients previously treated by surgery for melanoma or melanoma metastasis."3.665 years' experience of 5-S-cysteinyldopa in melanoma diagnosis. ( Agrup, G; Agrup, P; Andersson, T; Hafström, L; Hansson, C; Jacobsson, S; Jönsson, PE; Rorsman, H; Rosengren, AM; Rosengren, E, 1979)
"Determination of urine cysteinyldopa excretion is the most sensitive chemical test for the detection of melanoma metastases and has been successfully applied during the Scandinavian winter, when sun irradiation is low."3.66The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience. ( Nixon, PF, 1978)
"With the aid of gas chromatography and mass spectrometry a metabolite of dopa, 3-methoxytyrosine, has been demonstrated in the urine of 2 patients with melanoma metastases, the amounts excreted being 4."3.65Demonstration of 3-methoxytyrosine in the urine of melanoma patients. ( Agrup, G; Bengtsson, M; Falck, B; Persson, K; Rorsman, H; Rosengren, AM; Rosengren, E, 1976)
"A newly discovered amino acid, 5-S-cysteinyldopa, present in the urine of healthy subjects is excreted in pathological amounts in many patients suffering from melanoma metastases."3.655-S-cysteinyldopa in the urine of melanoma patients. ( Agrup, G; Agrup, P; Andersson, T; Falck, B; Hansson, JA; Jacobsson, S; Rorsman, H; Rosengren, AM; Rosengren, E, 1977)
"Information on evaluation of brain metastases is limited but encouraging."2.48Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT. ( Calabria, F; Chiaravalloti, A; Di Pietro, B; Grasso, C; Schillaci, O, 2012)
"The power of (18)F-FDOPA PET to predict disease progression was evaluated with the Kaplan-Meier and Cox regression methods."1.40(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. ( Allen-Auerbach, M; Chen, W; Czernin, J; DeSalles, AA; Lizarraga, KJ; Phelps, ME; Yong, WH, 2014)
"(68)Ga-DOTA-TATE PET delineated metastases in 54 of 55 positive metastatic tumour regions in contrast to 29 of 55 delineated by (18)F-DOPA PET."1.35Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours. ( Auernhammer, CJ; Bartenstein, P; Göke, B; Haug, A; Pöpperl, G; Schmidt, G; Tiling, R; Wängler, B, 2009)
"The greatest impact was observed for carcinoid tumors (50%: 11 of 22) and was clinically relevant in every case, followed by occult endocrine tumors (16%: four of 25), and was clinically relevant in three of the four cases, and noncarcinoid tumors (13%: 3 of 22), clinically relevant in only one case."1.35Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. ( Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN, 2009)
"The production of metastases and the differentiation of tumors in the present experiments appeared to be related to the genetic background of the mice and the epigenetic metabolic environment of tumors and cells."1.28Differentiation of new metastatic variants of B16 melanoma under different culture conditions. ( Ali-Mehidi, S; Aubert, C; Rouge, F; Voulot, C, 1992)

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-199037 (72.55)18.7374
1990's2 (3.92)18.2507
2000's3 (5.88)29.6817
2010's9 (17.65)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gornes, H1
Vaysse, C1
Deslandres, M1
Perallon, R1
Chantalat, E1
Rimailho, J1
de Hosson, LD1
van der Loo-van der Schaaf, AM1
Boellaard, R1
van Snick, JH1
de Vries, EGE1
Brouwers, AH1
Walenkamp, AME1
Balogova, S1
Talbot, JN2
Nataf, V2
Michaud, L1
Huchet, V2
Kerrou, K2
Montravers, F2
Lizarraga, KJ1
Allen-Auerbach, M1
Czernin, J1
DeSalles, AA1
Yong, WH1
Phelps, ME1
Chen, W1
Imperiale, A1
Rust, E1
Gabriel, S1
Detour, J1
Goichot, B1
Duclos, B1
Kurtz, JE1
Bachellier, P1
Namer, IJ1
Taïeb, D1
Guo, S1
Lin, CM1
Xu, Z1
Miao, L1
Wang, Y1
Huang, L1
Papin-Michault, C1
Bonnetaud, C1
Dufour, M1
Almairac, F1
Coutts, M1
Patouraux, S1
Virolle, T1
Darcourt, J1
Burel-Vandenbos, F1
Haug, A1
Auernhammer, CJ1
Wängler, B1
Tiling, R1
Schmidt, G1
Göke, B1
Bartenstein, P1
Pöpperl, G1
Lotz, JP1
Ruszniewski, P1
Rougier, P1
Duron, F1
Bouchard, P1
Grangé, JD1
Houry, S1
Kauhanen, S1
Schalin-Jäntti, C1
Seppänen, M1
Kajander, S1
Virtanen, S1
Schildt, J1
Lisinen, I1
Ahonen, A1
Heiskanen, I1
Väisänen, M1
Arola, J1
Korsoff, P1
Ebeling, T1
Sane, T1
Minn, H1
Välimäki, MJ1
Nuutila, P1
Calabria, F1
Chiaravalloti, A1
Di Pietro, B1
Grasso, C1
Schillaci, O1
GJESSING, LR1
BORUD, O1
Ambrosini, V1
Tomassetti, P1
Rubello, D1
Campana, D1
Nanni, C1
Castellucci, P1
Farsad, M1
Montini, G1
Al-Nahhas, A1
Franchi, R1
Fanti, S1
Paul, E2
Graef, V2
Ruppel, R2
Hellwich, M1
Marnot, D1
Decaux, F1
Berthelot, P1
Kalis, B1
Jardillier, JC1
Warren, L1
Bánfalvi, T1
Bezzegh, A1
Edesné, BM1
Fejös, Z1
Liszkay, G1
Schumann, B1
Kremmer, T1
Ottó, S1
Gilde, K1
Agrup, G8
Falck, B6
Kennedy, BM1
Rorsman, H13
Rosengren, AM9
Rosengren, E12
Andersson, T4
Persson, K2
Agrup, P3
Jacobsson, S4
Bengtsson, M1
Hansson, JA1
Hafström, L1
Hansson, C1
Jönsson, PE1
Nixon, PF1
Dy, V1
Watson, RC1
Exelby, PR1
Hajdu, SI1
Helson, L1
Aubert, C3
Rouge, F2
Foa, C1
Lipcey, C1
Cesarini, JP2
Daveau, M1
Picard, F1
Fournier, E1
Rivat, L1
Rivat, C1
Prota, G1
Lagrange, C1
Blois, MS2
Banda, PW1
Meunier, M1
Ali-Mehidi, S1
Voulot, C1
Hu, F1
Woodward, WR1
Peterson, LL1
Haberman, HF1
Menon, IA1
Minton, JP6
Dickey, RP4
Vogel, CL1
Dhru, D1
Ghozian, D1
Amor, B1
Delbarre, F1
Sohn, N1
Gang, H1
Gumport, SL1
Goldstein, M1
Deppisch, LM1
Greer, M1
Anton, AH1
Williams, CM1
Eichhorn, F1
Rutenberg, A1
Kott, E1
Duke, PS1
Domopoulos, HB1

Reviews

2 reviews available for dihydroxyphenylalanine and Neoplasm Metastasis

ArticleYear
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6

    Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorode

2013
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
    Nuclear medicine communications, 2012, Volume: 33, Issue:6

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging;

2012

Trials

3 trials available for dihydroxyphenylalanine and Neoplasm Metastasis

ArticleYear
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12

    Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Di

2011
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours.
    Nuclear medicine communications, 2007, Volume: 28, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Digestive System Neoplasms; Dihydroxyphenylalanine;

2007
[Letter: L. Dopa and bone metastases in breast cancer].
    La Nouvelle presse medicale, 1974, Mar-16, Volume: 3, Issue:11

    Topics: Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combination

1974

Other Studies

46 other studies available for dihydroxyphenylalanine and Neoplasm Metastasis

ArticleYear
Discovery of a neuroendocrine tumor of the caecum by mammary metastasis using 18F-DOPA-PET.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:12

    Topics: Adult; Breast Neoplasms; Cecal Neoplasms; Dihydroxyphenylalanine; Female; Humans; Neoplasm Metastasi

2018
Interlesional Heterogeneity of Metastatic Neuroendocrine Tumors Based on 18F-DOPA PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:8

    Topics: Aged; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Me

2019
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression;

2014
18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:3

    Topics: Adult; Aged; Cohort Studies; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal I

2014
Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation.
    ACS nano, 2014, May-27, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chromatography, High Pressure Liquid; C

2014
Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Brain Neoplasms; Dihydroxyphenylalanine; Female; Gene Expression Regulation, Neoplastic; Humans; Lar

2016
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5

    Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neopl

2009
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:4

    Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucos

2009
STUDIES OF FUNCTIONAL NEURAL TUMORS. VII. URINARY EXCRETION OF PHENOLIC PYRUVIC ACIDS.
    Scandinavian journal of clinical and laboratory investigation, 1965, Volume: 17

    Topics: Alkylation; Child; Chromatography; Dihydroxyphenylalanine; Humans; Metabolism; Neoplasm Metastasis;

1965
[5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Zeitschrift fur Hautkrankheiten, 1983, Feb-15, Volume: 58, Issue:4

    Topics: Cysteinyldopa; Dihydroxyphenylalanine; Humans; Isomerism; Melanoma; Neoplasm Metastasis; Skin Neopla

1983
Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Cancer detection and prevention, 1983, Volume: 6, Issue:1-2

    Topics: Adult; Aged; Cysteinyldopa; Dihydroxyphenylalanine; Female; Humans; Male; Melanoma; Middle Aged; Neo

1983
[5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Zeitschrift fur Hautkrankheiten, 1980, Dec-01, Volume: 55, Issue:23

    Topics: BCG Vaccine; Cysteinyldopa; Dihydroxyphenylalanine; Female; Humans; Male; Melanoma; Melphalan; Neopl

1980
[Determination of serum S-100 protein and 5-S-cysteinyl-DOPA levels in melanoma patients].
    Orvosi hetilap, 1999, Mar-14, Volume: 140, Issue:11

    Topics: Dihydroxyphenylalanine; Female; Humans; Male; Melanoma; Neoplasm Metastasis; S100 Proteins

1999
Formation of cysteinyldopa from glutathionedopa in melanoma.
    Acta dermato-venereologica, 1975, Volume: 55, Issue:1

    Topics: Animals; Cysteine; Depression, Chemical; Dihydroxyphenylalanine; Glutathione; Guinea Pigs; Humans; K

1975
5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Acta dermato-venereologica, 1975, Volume: 55, Issue:1

    Topics: Adult; Breast Neoplasms; Cysteine; Dihydroxyphenylalanine; Humans; Liver Neoplasms; Lung Neoplasms;

1975
Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Acta dermato-venereologica, 1975, Volume: 55, Issue:5

    Topics: Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm

1975
Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
    Acta dermato-venereologica, 1976, Volume: 56, Issue:1

    Topics: Chromatography, Gas; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Mass Spectrometry; Mela

1976
5-S-cysteinyldopa in the urine of melanoma patients.
    Acta dermato-venereologica, 1977, Volume: 57, Issue:2

    Topics: Adult; Aged; Cysteinyldopa; Dihydroxyphenylalanine; Eye Neoplasms; Female; Humans; Male; Melanoma; M

1977
5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Acta dermato-venereologica, 1979, Volume: 59, Issue:5

    Topics: Adult; Aged; Cysteinyldopa; Dihydroxyphenylalanine; Female; Hair Color; Humans; Lymphatic Metastasis

1979
The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
    The Australian and New Zealand journal of surgery, 1978, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Australia; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Neoplasm Meta

1978
Improved management of stage III neuroblastoma.
    Clinical bulletin, 1979, Volume: 9, Issue:2

    Topics: Age Factors; Antineoplastic Agents; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Human

1979
5-S-cysteinyldopa in diagnosis and treatment of human malignant melanomas and ultrastructural observations.
    European journal of cancer, 1977, Volume: 13, Issue:11

    Topics: Adult; Aged; Cysteinyldopa; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Melanoma; Micros

1977
[Urinary evaluation of 5-S-cysteinyldopa and seric evaluation of IgG4 subclass during follow-up of 27 primitive malignant melanomas (author's transl)].
    Annales de dermatologie et de venereologie, 1978, Volume: 105, Issue:4

    Topics: Cysteinyldopa; Dihydroxyphenylalanine; Humans; Immunoglobulin G; Melanoma; Neoplasm Metastasis

1978
[Melanoma metabolites (proceedings)].
    Lakartidningen, 1978, Dec-06, Volume: 75, Issue:49

    Topics: Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Neoplasm Metastasis; Skin Neoplasms

1978
Isolation of 2-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa from the urine of patients with melanoma.
    Experientia, 1977, Jun-15, Volume: 33, Issue:6

    Topics: Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Neoplasm Metastasis

1977
Catechols in primary and metastatic human malignant melanoma cells in monolayer culture.
    European journal of cancer, 1976, Volume: 12, Issue:6

    Topics: Adult; Clone Cells; Dihydroxyphenylalanine; Female; Humans; Male; Melanocytes; Melanoma; Middle Aged

1976
Detection of occult metastatic melanoma by urine chromatography.
    Cancer research, 1976, Volume: 36, Issue:9 pt.1

    Topics: Chromatography, Ion Exchange; Cysteinyldopa; Dihydroxyphenylalanine; Female; Humans; Male; Melanoma;

1976
[Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    La Revue du praticien, 1975, Volume: 25, Issue:51

    Topics: Creatinine; Cysteine; Dihydroxyphenylalanine; Melanoma; Neoplasm Metastasis; Skin Neoplasms

1975
[Chemical diagnosis of melanoma].
    Lakartidningen, 1976, Feb-11, Volume: 73, Issue:7

    Topics: Cysteine; Dihydroxyphenylalanine; Humans; Melanoma; Neoplasm Metastasis; Skin Neoplasms

1976
Differentiation of new metastatic variants of B16 melanoma under different culture conditions.
    Pigment cell research, 1992, Volume: 5, Issue:1

    Topics: Animals; Cell Transformation, Neoplastic; Dihydroxyphenylalanine; Genetic Variation; Lung Neoplasms;

1992
Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice.
    The Journal of investigative dermatology, 1988, Volume: 90, Issue:2

    Topics: Animals; Cysteinyldopa; Dihydroxyphenylalanine; Male; Melanoma, Experimental; Mice; Mice, Inbred C57

1988
Presence and properties of tyrosinase in sera of melanoma-bearing animals.
    Acta dermato-venereologica, 1971, Volume: 51, Issue:6

    Topics: Animals; Blood; Catechol Oxidase; Centrifugation, Density Gradient; Chromatography; Cricetinae; Dihy

1971
Prolactin, F.S.H., and L.H. in breast cancer: effect of levodopa and oophorectomy.
    Lancet (London, England), 1972, May-13, Volume: 1, Issue:7759

    Topics: Adult; Bone Neoplasms; Breast Neoplasms; Dihydroxyphenylalanine; Female; Follicle Stimulating Hormon

1972
Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans.
    Acta dermato-venereologica, 1974, Volume: 54, Issue:1

    Topics: Adult; Aged; Black People; Cysteine; Dihydroxyphenylalanine; Female; Humans; Male; Melanoma; Middle

1974
5-S-cysteinyldopa in melanomas of Caucasians.
    Acta dermato-venereologica, 1974, Volume: 54, Issue:1

    Topics: Adult; Aged; Chromatography; Cysteine; Dihydroxyphenylalanine; Female; Fluorometry; Hair; Humans; Me

1974
Prolactin and human breast cancer.
    American journal of surgery, 1974, Volume: 128, Issue:5

    Topics: Antipsychotic Agents; Bone Neoplasms; Breast Neoplasms; Castration; Dihydroxyphenylalanine; Estrogen

1974
Melanocytic neoplasms.
    Clinical pharmacology and therapeutics, 1974, Volume: 16, Issue:5 Part 2

    Topics: Dihydroxyphenylalanine; Epinephrine; Humans; Melanins; Melanocytes; Melanoma; Mustard Compounds; Neo

1974
L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report.
    American journal of obstetrics and gynecology, 1972, Sep-15, Volume: 114, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Bone Neoplasms; Breast Neoplasms; Dihydroxyphenyl

1972
Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands.
    Surgery, gynecology & obstetrics, 1973, Volume: 136, Issue:6

    Topics: Adenocarcinoma; Adult; Analgesics; Bone Neoplasms; Breast Neoplasms; Dihydroxyphenylalanine; Female;

1973
Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
    The Yale journal of biology and medicine, 1973, Volume: 46, Issue:5

    Topics: Animals; Black People; Cysteine; Dihydroxyphenylalanine; Dopamine; Fluorometry; Guinea Pigs; Hair; H

1973
Proceedings: The response of breast cancer patients with bone pain to L-dopa.
    Cancer, 1974, Volume: 33, Issue:2

    Topics: Adrenalectomy; Bone Neoplasms; Breast Neoplasms; Castration; Dihydroxyphenylalanine; Female; Humans;

1974
Generalized melanosis secondary to malignant melanoma. Report of a case with serum and tissue tyrosinase studies.
    Cancer, 1969, Volume: 24, Issue:5

    Topics: Catechol Oxidase; Dihydroxyphenylalanine; Female; Humans; Lung Neoplasms; Melanins; Melanoma; Melano

1969
Levodopa relief of bone pain from breast cancer.
    The New England journal of medicine, 1972, Apr-13, Volume: 286, Issue:15

    Topics: Adult; Bone Neoplasms; Breast Neoplasms; Dihydroxyphenylalanine; Female; Humans; Neoplasm Metastasis

1972
Failure of enzyme inhibition therapy for malignant melanoma.
    Transactions of the American Neurological Association, 1969, Volume: 94

    Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Dopamine; Enzyme Repression; Epinephrine; Humans; Ma

1969
Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
    Clinical chemistry, 1971, Volume: 17, Issue:4

    Topics: Aluminum; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine; Electrophoresis; Ethylenediamines; Fluor

1971
One-dimensional paper chromatographic method for determination of urinary homovanillic acid.
    Clinical chemistry, 1968, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Aged; Chromatography, Paper; Dihydroxyphenylalanine; Female; Humans; Male; Melani

1968